Real-world evidence (RWE) was discussed as a key topic during 40% of the technology appraisals conducted by NICE in the year since October 2022, while in 20% of cases it was accepted as the primary piece of evidence during health technology assessments (HTAs), a conference has heard.
RWE Accepted As ‘Primary Evidence’ In 20% Of NICE Appraisals Over Past Year
NICE, the health technology assessment body for England and Wales, says it has seen “good uptake” of its new evaluation methods manual and real-world evidence framework, both introduced last year.
